MEDORA PHARMA
Funded by epileptics, Led by epileptics, Benefitting epileptics
About us
Medora Pharma is pioneering the future of epilepsy care with a groundbreaking approach aimed at predicting seizures before they happen. We are currently developing a device aimed at detecting epileptic seizures 5–10 minutes before they occur, which will offer peace of mind and a new level of safety for patients. Co-founder Armand Fatalot, who lives with epilepsy himself, understands firsthand the anxiety that the unpredictable nature of seizures can cause, and Medora is dedicated to addressing this challenge.
What sets Medora apart is our commitment to working hand in hand with patients. We are the first pharmaceutical company to build and support a thriving community of individuals affected by epilepsy, inviting them to help guide our research and development in the most productive direction. Through our patient communities, we gain invaluable insights that ensure our solutions directly address the needs of those we aim to serve.
Our innovative crowdfunding model allows patients and supporters to take an active role in shaping the future of epilepsy treatment. Members of our community are empowered to contribute to funding efforts and participate in key decision-making processes through voting, ensuring that our initiatives remain patient-centric every step of the way. Together, we are creating a future where epilepsy care is proactive, personalized, and built on a foundation of true partnership between researchers, doctors, and patients.
Our Mission
Reducing Seizure-Related Injuries by 80%
Our mission is to reduce seizure-related injuries by 80%, empowering people with epilepsy to live safer, fuller lives. By predicting seizures, our technology minimizes the risks associated with unexpected episodes, giving individuals greater control over their daily activities.
Empowering Patients through Collaboration
We believe the best solutions come from working closely with patients. Our goal is to build devices that meet real needs, focusing on usability and accessibility, while making people with epilepsy partners in shaping their care.
Leading the Future of Medical Diagnostics
Medora aims to lead in epilepsy management and noninvasive diagnostics. Our goal is to expand beyond epilepsy to provide fast, patient-centered tools for a wide range of medical conditions, making advanced diagnostics accessible to all.